# Use of Labeled Glucose to Study Lymphocyte Replication and Survival in HIV-Infected Patients

> **NCT00001651** · NA · TERMINATED · sponsor: **National Institute of Allergy and Infectious Diseases (NIAID)** · enrollment: 54 (actual)

## Conditions studied

- HIV
- Healthy Volunteers

## Interventions

- **OTHER:** [6,6-2H2]-glucose

## Key facts

- **NCT ID:** NCT00001651
- **Lead sponsor:** National Institute of Allergy and Infectious Diseases (NIAID)
- **Sponsor class:** NIH
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 1998-02-25
- **Primary completion:** 2020-01-01
- **Final completion:** 2020-05-29
- **Target enrollment:** 54 (ACTUAL)
- **Why stopped:** Slow/Insufficient accrual
- **Last updated:** 2020-06-01


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00001651

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00001651, "Use of Labeled Glucose to Study Lymphocyte Replication and Survival in HIV-Infected Patients". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT00001651. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*